Clinical Trials in Prague, Prague

12 recruiting

Showing 19 of 9 trials

Recruiting
Phase 2Phase 3

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Acute Myeloid LeukemiaMyelodysplastic SyndromesChronic Myelomonocytic Leukemia+1 more
Taiho Oncology, Inc.316 enrolled73 locationsNCT04256317
Recruiting
Phase 3

Study to Assess the Safety and Effectiveness of NMRA-335140-501

Major Depressive Disorder
Neumora Therapeutics, Inc.1,000 enrolled177 locationsNCT06029439
Recruiting
Phase 3

A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Ferring Pharmaceuticals250 enrolled64 locationsNCT06545955
Recruiting
Phase 3

Neoadjuvant Darovasertib in Primary Uveal Melanoma

Uveal Melanoma
IDEAYA Biosciences520 enrolled87 locationsNCT07015190
Recruiting
Phase 3

Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive Disorder

Major Depressive Disorder
Neumora Therapeutics, Inc.332 enrolled71 locationsNCT06058039
Recruiting
Phase 3

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia
PedAL BCU, LLC98 enrolled89 locationsNCT05183035
Recruiting
Phase 3

High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

High Risk NeuroblastomaPatient With Insufficient Response Chemoimmunotherapy
Gustave Roussy, Cancer Campus, Grand Paris800 enrolled142 locationsNCT04221035
Recruiting
Not Applicable

Strength-Endurance Circuit Training in Parkinson's Disease

Parkinson Disease, Idiopathic
General University Hospital, Prague90 enrolled1 locationNCT06893055
Recruiting
Phase 2

Diagnostic Accuracy Study for OWL-EVO1 As a Lung Cancer EVOC® Probe (Evolution Phase 2)

Lung Cancer
Owlstone Ltd350 enrolled9 locationsNCT06193239